Innovation1 Biotech Stock Alpha and Beta Analysis

IVBT Stock  USD 0  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Innovation1 Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Innovation1 Biotech over a specified time horizon. Remember, high Innovation1 Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Innovation1 Biotech's market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Innovation1 Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Innovation1 Biotech did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Innovation1 Biotech stock's relative risk over its benchmark. Innovation1 Biotech has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Innovation1 Biotech are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Innovation1 Biotech Backtesting, Innovation1 Biotech Valuation, Innovation1 Biotech Correlation, Innovation1 Biotech Hype Analysis, Innovation1 Biotech Volatility, Innovation1 Biotech History and analyze Innovation1 Biotech Performance.

Innovation1 Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Innovation1 Biotech market risk premium is the additional return an investor will receive from holding Innovation1 Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innovation1 Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Innovation1 Biotech's performance over market.
α0.00   β0.00

Innovation1 Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Innovation1 Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Innovation1 Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Innovation1 Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how Innovation1 Biotech otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innovation1 Biotech shares will generate the highest return on investment. By understating and applying Innovation1 Biotech otc stock market price indicators, traders can identify Innovation1 Biotech position entry and exit signals to maximize returns.

Innovation1 Biotech Return and Market Media

The median price of Innovation1 Biotech for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 0.001 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Innovation1 Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Innovation1 or other otcs. Alpha measures the amount that position in Innovation1 Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Innovation1 Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Innovation1 Biotech's short interest history, or implied volatility extrapolated from Innovation1 Biotech options trading.

Build Portfolio with Innovation1 Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Innovation1 OTC Stock Analysis

When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.